StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report report published on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Performance
Shares of AEZS stock opened at $3.55 on Friday. Aeterna Zentaris has a fifty-two week low of $3.96 and a fifty-two week high of $12.00. The stock has a 50 day moving average price of $3.06 and a two-hundred day moving average price of $3.03. The company has a market capitalization of $6.37 million, a P/E ratio of -0.24 and a beta of 1.55.
About Aeterna Zentaris
Featured Stories
- Five stocks we like better than Aeterna Zentaris
- How to Plot Fibonacci Price Inflection Levels
- Constellation Powers Up With Reinforced AI Data Center Strategy
- Bank Stocks – Best Bank Stocks to Invest In
- Top Analyst-Rated Healthcare Stocks to Watch Now
- 3 Dividend Kings To Consider
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.